NASDAQ:TWST Twist Bioscience Q4 2026 Earnings Date & Estimates $132.75 -11.74 (-8.13%) Closing price 10/16/2026 04:00 PM EasternExtended Trading$131.30 -1.45 (-1.09%) As of 10/16/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Twist Bioscience is estimated to report Q4 2026 earnings on Friday, November 13, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ4 2026Announcement DateNovember 13, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Twist Bioscience in Q4 2026Twist Bioscience is expected to post earnings of -$0.3845 per share on revenue of $123.59 million. In the same quarter a year earlier Twist Bioscience reported -$0.45 per share on revenue of $99.01 million. Twist Bioscience last reported on August 3, 2026, posting -$0.56 per share and missing the -$0.5063 consensus estimate. Twist Bioscience has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.3845Expected Revenue$123.59 millionPrior-Year EPS-$0.45Prior-Year Revenue$99.01 millionExpected Revenue Growth+24.8%Recent Track RecordLast ReportedQ3 2026Last Quarter EPS-$0.56 (Missed by -$0.0538)Last Quarter Revenue$118.38 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q4 2026 CallEarnings HistoryCompany ProfileQ3 2026 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Twist Bioscience Q4 2026 Earnings FAQ When does Twist Bioscience report Q4 2026 earnings? Twist Bioscience (NASDAQ:TWST) is estimated to report Q4 2026 earnings on Friday, November 13, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Twist Bioscience's Q4 2026 earnings call? Twist Bioscience's Q4 2026 earnings conference call is scheduled for Friday, November 13, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Twist Bioscience? Analysts expect Twist Bioscience to post earnings of -$0.3845 per share for Q4 2026. How much revenue is Twist Bioscience expected to report? The consensus revenue estimate for Twist Bioscience is $123.59 million for Q4 2026. Twist Bioscience Earnings HeadlinesIs Twist Bioscience (TWST) Quietly Becoming Core Infrastructure for AI-Driven Biofoundry Platforms?October 14, 2026 | uk.finance.yahoo.comThese 3 stocks are crushing the magnificent seven this year -- are they still buys?October 12, 2026 | msn.comElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.October 18 at 1:00 AM | Brownstone Research (Ad)Bullfrog AI (NASDAQ:BFRG) & Twist Bioscience (NASDAQ:TWST) Head-To-Head ContrastOctober 12, 2026 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Stock: Insider Emily Leproust Sells 4,548 SharesOctober 9, 2026 | americanbankingnews.comTwist Bioscience: Valuation Stretched As AI Drug Discovery Hype Outpaces RealityOctober 8, 2026 | seekingalpha.comSee More Twist Bioscience Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Twist Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Twist Bioscience and other key companies, straight to your email. Email Address About Twist BioscienceTwist Bioscience (NASDAQ:TWST) (NASDAQ:TWST) is a biotechnology company that develops and manufactures synthetic DNA using a silicon-based production platform. Its technology is designed to enable the precise, high-throughput synthesis of DNA at smaller scale and with potentially lower material consumption than traditional methods. The company provides synthetic DNA products and services for applications in drug discovery and development, biotechnology research, agriculture, industrial chemicals and other life sciences markets. Its offerings include synthetic genes, oligonucleotides, gene fragments, variant libraries and next-generation sequencing target-enrichment products. Twist also supports data-storage research and other emerging applications for synthetic biology. Twist Bioscience was founded in 2013 and is headquartered in South San Francisco, California. The company serves customers globally through its commercial operations and online ordering platform. Co-founder Emily M. Leproust has served as chief executive officer since the company’s founding.View Twist Bioscience ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/12 - 10/16Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?Bank of America Stock Sell-Off Looks Like a Buying OpportunityManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay SolidMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?These 2 Gold Miners Just Flashed Golden Crosses—Is a Breakout Coming? Upcoming Earnings America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026)Northrop Grumman (10/20/2026)RTX (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
